Huntington National Bank
OLMA icon

Huntington National Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Huntington National Bank’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13 Hold
1
– – ﹤0.01% 3837
2026
Q1 		$15 Hold
1
– – ﹤0.01% 3611
2025
Q4 		$25 Hold
1
– – ﹤0.01% 3263
2025
Q3 		$10 Hold
1
– – ﹤0.01% 3711
2025
Q2 		$4 Sell
1
-625
-100% -$2.79K ﹤0.01% 3901
2025
Q1 		$2.35K Sell
626
-20
-3% -$101 ﹤0.01% 2184
2024
Q4 		$3.77K Buy
646
+35
+6% +$350 ﹤0.01% 2087
2024
Q3 		$7.3K Sell
611
-33
-5% -$422 ﹤0.01% 1874
2024
Q2 		$6.97K Buy
+644
New +$6.98K ﹤0.01% 1817

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Huntington National Bank's OLMA Position: Q2 2026 in Review

Huntington National Bank held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

Huntington National Bank first reported a position in OLMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.3K in Q3 2024. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Huntington National Bank held 1 share of Olema Pharmaceuticals worth $13 as of Q2 2026.
  • Huntington National Bank left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #3837 holding.
  • Huntington National Bank first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Huntington National Bank's Olema Pharmaceuticals position peaked at $7.3K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.